The scope of work for the Core involves the establishment of a molecular epidemiology facility for the Cancer Center. This Core will be responsible for consulting with cancer members on molecular and genetic epidemiology and receiving, processing, barcode labeling and archiving blood, buccal, bone marrow, Guthrie blood spots, frozen and fixed tumor specimens. The Core will isolate DNA for genotyping studies and will coordinate their use with the other cores of the Cancer Center. In addition, the Core will carry out DNA adduct studies of tissue or peripheral mononuclear cells. Specifically the aims of the core are the following; To provide consultation to members concerning molecular epidemiology study design, incorporating appropriate biomarkers, advise on feasibility, sharing protocols, and questionnaires; To assist investigators carry out pilot studies. Provide field testing of protocols and biomarker assays for preliminary results for grant submissions; Specimen banking, tracking and database linkage. Provide processing, bar code labeling, storage, and customized tracking of biological specimens; cells, serum, blood, DNA, buccal cells, bone marrow, Guthrie cards, whole genome amplification (WGA) products; Special processing for genetic analyses. Carry out whole genome amplification and validation testing of buccal cells, Guthrie cards & other limited specimens and; Provide molecular analyses not available through other Cancer Center Cores. Specialized genotyping, methylation studies in fresh and paraffin embedded tissues, translocation breakpoint cloning/identification, DNA adduct measurements.
| Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131: |
| Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228 |
| Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408 |
| Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279 |
| Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380 |
| Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485 |
| An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575 |
| Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3: |
| Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607 |
| An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794 |
Showing the most recent 10 out of 192 publications
